Monthly Journal of Pharmaceutical Business (2020.09.01, Iyaku Keizai) carries an interview article with PGV CEO.
PGV obtains License Certificate for Selling and Leasing Specially-Controlled Medical Device on August 17, 2020.
PGV obtains a medical device certification for “Patch-Type EEG HARU-1.”
PGV raises 150 million yen through third-party allotment of new shares to OSAKA University Venture Capital Co., Ltd.
Recruiting information updated; an opening for a brain-wave data analyst position.
2020.4.1 Nikkei Business Daily covers PGV’s business leveraging its patch-type EEG sensor, jointly developed with Nippon Mektron.
PGV obtains permits for “Marketing of Class II Medical Devices” and “Manufacturing of Medical Devices.”
2020.3.3.Weekly Economist covers PGV in its article, “Challenger 2020.”